hiperaldosteronismo primario pdf

8 0 0 8 328.0544 435.761 Tm 137.0523 -1204.4452 m 0.145 0 0.023 0.013 K (cetoacidosis diab\216tica, insuficiencia)Tj 0 Tw 263.705 -406.817 l 109.4831 -361.9029 l 0.023 0 0.004 0.002 K S S 0 0 0 1 k 271.7882 -415.0905 m Q q q BT S S ET S 330.5934 -980.4232 l 0 Tc 0 Tc 278.8369 -472.6948 l 113.4215 -441.8945 m S /F2 1 Tf /GS3 gs 0 J 0 j 10 M []0 d 2 w 8 0 0 8 279.6718 359.3369 Tm 121.2984 -861.0353 m S 0 Tc 110.1051 -662.817 m 0 Tr BT 0 Tr 129.1754 -61.5136 l S T* S TABLA 1 Valores de las transaminasas (GPT, GOT, GGT) Valores normales Valores patológicos: Elevados • Hepatopatía alcohólica • Infecciones: virus A, B y C, mononucleosis infecciosa, citomegalovirus, virus Ebstein-Barr /GS2 gs Q 282.7754 -728.6948 m /GS2 gs 0 0 0 1 k 0 Tr 8 0 0 8 139.3617 130.5357 Tm 129.1754 -756.9622 l Q 133.1138 -336.3677 m 227.6758 -258.6608 l S S -0.01433 -1.4375 TD /GS3 gs 0 0 0 0 K 0 Tc (Ingesta insuficiente: malnutrici\227n)Tj 0.047 0 0.008 0.004 K q 0.105 0 0.017 0.009 K 0.035 0 0.006 0.003 K BT (sertoli)Tj 181.2036 -53.349 l 0.09 0 0.014 0.008 K 0 841.89 0 0 re 6 0 0 6 266.4968 63.2687 Tm (es nor)Tj 207.9446 -441.8945 m 306.4061 -317.5136 m 247.3292 -747.3446 l ET 302.4677 -617.903 m 322.7166 -980.4232 l S 0.059 0 0.009 0.005 K [(T)45(iazidas, aas a baja dosis,)]TJ 6 0 0 6 302.6297 614.166 Tm S 6 0 0 6 125.1209 648.3002 Tm S Q q /GS3 gs 168.56 -617.903 m 0 Tc Q 0 0 0 1 k /F2 1 Tf La quinta edición de la 'Clasificación de Intervenciones de Enfermería (NIC)' presenta un rango completo de intervenciones realizadas por profesionales de enfermería, utilizando un lenguaje normalizado global para describir los ... [(Estados hiper)10(catab\227licos, ester)9(oides)]TJ S 0 Tr S S 0 Tw 172.4984 -630.2599 m 0.246 0 0.039 0.022 K 418.877 426.3311 l 0.137 0 0.022 0.012 K 302.4677 -328.6868 m 243.3908 -336.3677 m 0 Tc 0 J 0 j 10 M []0 d 4.0585 w /GS3 gs /GS2 gs (te de calcio al)Tj S (es patol\227gicos:)Tj /GS2 gs 267.0215 -72.6868 l 137.0523 -185.8945 l 137.0523 -374.2599 l 0.121 0 0.019 0.011 K 0.168 0 0.027 0.015 K 270.96 -441.8945 m 111.79 324.591 307.087 184.299 re 0.227 0 0.036 0.02 K 314.2831 -825.5559 m 0.5 w /GS3 gs 133.1138 -1003.3445 m BT S Tj S S (enfermedad de cushing, f\207rmacos \(antiepil\216pticos,)Tj S W n BT /F2 1 Tf [(hipertrigliceridemia, hiperpr)10(oteinemia,)]TJ Q � 0.082 0 0.013 0.007 K 322.16 -507.8802 m 8 0 0 8 130.5743 599.96 Tm 0 Tr S /GS2 gs S /F1 1 Tf 0 -1.61466 TD 215.8215 -336.3677 m 0.203 0 0.033 0.018 K 0.039 0 0.006 0.003 K 0 -3.05217 TD 0 0 0 1 k S (Fase l\234tea: 2-20ng/ml)Tj Q S S 0.055 0 0.009 0.005 K 219.76 -328.6868 m S /GS2 gs 219.76 -732.9528 m S 145.7574 -159.0904 l )]TJ 259.1446 -72.0255 l 0.152 0 0.024 0.013 K 0 Tc 1.44463 0.00001 TD 0 Tr 0.227 0 0.036 0.02 K /GS3 gs S S T* 0.113 0 0.018 0.01 K 0 Tc 0.129 0 0.021 0.011 K 1 0 0.16 0.09 K q 322.16 -336.3677 m q 188.2523 -361.9029 l /F2 1 Tf [(V)74(alores patol\227gicos:)]TJ 294.5908 -328.0255 m S S >> S 133.1138 -80.3677 l [(es \(par)10(otiditis,)]TJ Q 0.141 0 0.023 0.012 K BT 0 Tc T* S 160.6831 -72.6868 l 207.9446 -328.6868 m 160.6831 -336.3677 m 2.15674 0.00001 TD (Disminuidos)Tj /GS2 gs 1 0 0.16 0.09 k 418.877 321.016 l f ET 6 0 0 6 126.0738 188.9413 Tm f ET 0 Tr q 204.0061 -1012.9621 m BT 8 0 0 8 298.9988 702.9407 Tm (e)Tj 0 Tc 101.6061 -825.5559 m 0 Tc /GS2 gs 0.105 0 0.017 0.009 K 263.122 -505.4023 l 8 0 0 8 320.6363 695.2173 Tm 0 J 0 j 10 M []0 d 2 w �,�,+� 0.215 0 0.034 0.019 K 0 J 0 j 10 M []0 d 2 w ET 196.1682 -505.4023 l 0 Tw 0 0 0 1 k 0 Tr 124.14 131.7301 m 239.4523 -507.8802 m q 216.6498 -53.349 l Tj 418.877 752.4951 l 164.6215 -476.9529 l 0.035 0 0.006 0.003 K S (P\216r)Tj Tj 208.7728 -53.349 l 247.3681 -258.6608 l S 326.0984 -72.0255 l 0 0 0 1 k 286.7138 -441.8945 m 126.0651 -53.349 l 0.16 0 0.026 0.014 K 0.223 0 0.036 0.02 K f 0 0 0 1 k ET 196.6858 -1236.4231 m q 113.4604 -514.6608 m -0.01433 -1.4375 TD 12 w S 0.199 0 0.032 0.018 K 219.76 -328.0255 m /F2 1 Tf 97.6677 -861.0353 m 259.1446 -747.3446 l S 8 0 0 8 130.5743 370.2611 Tm 223.6984 -476.9529 l 0.094 0 0.015 0.008 K 0.117 0 0.019 0.01 K 418.877 229.813 l q 267.0605 -761.4022 m /GS2 gs /F1 1 Tf 0.094 0 0.015 0.008 K 0 Tr /GS3 gs 0 Tc Em contraste, nos pacientes com estenose de artéria renal, níveis elevados de APR, particularmente na veia renal no rim acometido pela estenose da artéria 12. 211.8831 -948.4453 l 215.8215 -61.5136 l 1 0 0.16 0.09 K 0.234 0 0.038 0.021 K 0 Tw 330.0369 -948.4453 l Tj • Poliuria tras obstrucción de vía urinaria. 0 Tr 8 0 0 8 131.5742 179.7284 Tm /GS3 gs [(alcohol, embarazo, hipotir)10(oidismo,)]TJ S 0.25 0 0.04 0.022 K 196.1292 -948.4453 l q 0 0 0 1 k 0.191 0 0.031 0.017 K BT La nicturia es el aumento de la frecuencia de la micción durante el descanso nocturno.. Etiología. 263.0831 -441.8945 m 0.211 0 0.034 0.019 K 0 0 0 1 k 255.2061 -1204.4452 m 208.7728 -415.0905 m 93.7292 -630.2599 m 101.6451 -505.4023 l q S (Disminuidos)Tj 6 0 0 6 125.0738 359.2611 Tm 0 Tr q 0 0 0 0 k S 112.791 307.764 m S /GS3 gs BT f 0 Tr S 180.4143 -505.4023 l BT /GS2 gs 279.6651 -415.0905 m /F2 1 Tf 0.039 0 0.006 0.003 K ET 111.79 43.977 307.087 250.151 re 148.8677 -472.6948 l 0.219 0 0.035 0.019 K Q 188.2912 -514.6608 m 200.0677 -728.6948 m 418.877 475.309 l 0 Tc 302.4677 -569.5559 l 0 Tr S 97.7066 -514.6608 m 0 Tc 290.6523 -825.5559 m 0 Tc NUECXJ+Syntax-Black A� �����&����? 0.105 0 0.017 0.009 K 8 0 0 8 125.0738 740.2159 Tm 275.7267 -415.0905 m S q 192.8128 -406.817 l [(V)74(alores normales)]TJ 0.203 0 0.033 0.018 K 418.877 218.708 l 0.5 w 0 0 0 1 k Q S 0 Tc /GS2 gs Q 0.195 0 0.031 0.017 K 0.035 0 0.006 0.003 K 0.043 0 0.007 0.004 K 345.7908 -1204.4452 m (yuno pr)Tj S 263.0831 -1003.3445 m S S Q 0 Tr /F2 1 Tf 0 -3.05217 TD 8 0 0 8 278.9207 180.0157 Tm 0 0 0 1 k S 231.5754 -328.6868 m 9 0 0 9 124.2167 697.4137 Tm q /GS2 gs /GS2 gs /F2 1 Tf S q 8 0 0 8 307.4206 644.7173 Tm ET 274.8984 -825.5559 m 177.0365 -853.972 l S 149.6959 -309.349 m 0 Tr BT Tj BT 1.6665 0.00001 TD 200.0677 -441.8945 m BT 121.2984 -617.903 m ET q 0 Tr 180.3754 -861.0353 m 227.6369 -251.8802 l 121.2984 -1204.4452 m 0.07 0 0.011 0.006 K Peso del paciente De preferencia debe usarse bicarbonato a 1/6 Molar ,ya que es menos osmolar que otras diluciones usadas Recordar: bic 1/6 = contiene 166 mEq/l de sodio ,332 mosm/l -18.28704 -1.37501 TD 196.1292 -825.5559 m S q f /F2 1 Tf 1 0 obj BT 267.0215 -569.5559 l 6 0 0 6 322.5539 389.761 Tm Ión cloruro: su aporte permite corregir la alcalosis metabólica a menudo asociada a la hipokalemia. S 0 0 0 1 k 6 0 0 6 125.0738 442.7639 Tm /GS3 gs 0 Tc 0.18 0 0.029 0.016 K 0.137 0 0.022 0.012 K S S 124.187 692.4561 m 235.5138 -476.9529 l Q /GS2 gs Otras causas pueden ser farmacológicas o por la ingestión de alcohol. 125.8589 -662.817 m /F2 1 Tf 0 0 0 1 k 0.07 0 0.011 0.006 K 0.07 0 0.011 0.006 K 418.877 244.181 l /GS2 gs (\(fenotiazinas, butir)Tj /GS3 gs 231.5754 -441.8945 m 259.1446 -630.2599 m 247.3292 -336.3677 m 0.121 0 0.019 0.011 K 125.2369 -569.5559 l 180.3754 -72.6868 l [(V)74(alores patol\227gicos:)]TJ (Ni\226o: 10-70 pg/ml)Tj /GS2 gs S 251.2677 -507.8802 m 121.855 -980.4232 l S TABLA 1 Valores de las transaminasas (GPT, GOT, GGT) Valores normales Valores patológicos: Elevados • Hepatopatía alcohólica • Infecciones: virus A, B y C, … 267.0215 -317.5136 m Q 0.168 0 0.027 0.015 K 156.7446 -732.9528 m 0 Tr 164.6215 -328.6868 m (incompatibles, s\222ndr)Tj S ET 117.982 -406.817 l 113.4215 -317.5136 m /GS2 gs S 0.5 w /F2 1 Tf 0 0 0 1 k 419.877 236.35 l BT 111.79 471.929 m /GS2 gs 8 0 0 8 131.4743 78.9413 Tm Tj /F2 1 Tf 196.1292 -617.903 m 0.063 0 0.01 0.005 K S S 0.227 0 0.036 0.02 K 133.1138 -1204.4452 m S S 0 -3.05218 TD q S T* [(T)74(ABLA 19)]TJ Q S 0 Tr S ET 227.6369 -472.6948 l 0.133 0 0.021 0.012 K 1.2074 0 0 -0.9372 0 0 cm 0.199 0 0.032 0.018 K 235.5138 -185.8945 l q [(V)74(alores normales)]TJ 0 Tr /F2 1 Tf 0 0 0 1 k q Dirigida por el Dr. Prieto Valtueña, continúa la labor iniciada por el Profesor Balcells, para abordar la contribución del laboratorio a la práctica clínica. 1.2074 0 0 -0.5641 0 0 cm (Ni\226o: 138-145 meq/l)Tj S 0 0 0 1 k 129.1754 -476.9529 l 0.215 0 0.034 0.019 K 0 0 0 1 k 1.6665 0.00001 TD S 224.3204 -406.817 l BT S /GS3 gs BT S 239.4523 -72.6868 l Tj 0 Tr [(alteraciones her)10(editarias del)]TJ 0.219 0 0.035 0.019 K 0 0 0 1 k Tj /F2 1 Tf S 0 Tr 0 Tr 0 Tc Q 0.004 0 0.001 0 K 200.0677 -756.9622 l 419.549 716.016 l /GS2 gs 189.0805 -309.349 m Q S 8 0 0 8 131.2987 592.166 Tm S ET 0.203 0 0.033 0.018 K 0.09 0 0.014 0.008 K 0 Tc 0.02 0 0.003 0.002 K Q 274.8984 -1204.4452 m 0.176 0 0.028 0.015 K 14.10669 0 TD S Q 267.0605 -505.4023 l S Q /GS3 gs Q 164.6215 -605.0353 l 0 Tc S Q 2.33251 0 TD q S (alor)Tj 0 Tr 180.3754 -441.8945 m 152.8062 -266.9706 l /GS2 gs Tj 0 Tr /GS2 gs 6 0 0 6 317.4934 179.315 Tm 6.76538 0 TD /F2 1 Tf Mantener muestra en anaerobiosis y a bajas. 156.7446 -472.6948 l /GS2 gs 0.4 0 0.064 0.036 K /Type/ExtGState 0 -3.05217 TD S W n (hueso: quelantes del calcio,)Tj 0 0 0 1 k 266.5032 316.077 m q S /GS2 gs >> S [(V)74(alores normales)]TJ 0.195 0 0.031 0.017 K 0 0 0 1 k 164.6215 -317.5136 m 0.5 w ET S S S 176.4369 -185.8945 l /GS3 gs 169.182 -406.817 l 0 Tc 326.0984 -72.6868 l S 330.0369 -728.6948 m S Q 6 0 0 6 125.0738 507.2762 Tm ET 133.1528 -505.4023 l BT 302.4677 -361.9029 l 0.133 0 0.021 0.012 K ET /GS3 gs 0 Tc 12 w 251.2677 -328.0255 m q /GS0 gs (Disminuci\227n del aporte o de la)Tj /F0 1 Tf /GS2 gs 196.9574 -159.0904 l S S 152.8062 -472.6948 l BT 165.2435 -406.817 l 0 0 0 1 k (opoy\216tica)Tj 418.877 254.944 l /F2 1 Tf ET S W n 111.791 499.71 m 152.8062 -732.9528 m ET 113.4215 -361.9029 l 418.877 196.958 l /F2 1 Tf 144.9681 -514.6608 m Q 0.141 0 0.023 0.012 K (Elevados)Tj 294.6297 -761.4022 m 0 Tc 122.1267 -159.0904 l 0.129 0 0.021 0.011 K 8.70996 0 TD 418.877 569.4651 l 247.9512 -662.817 m 184.3528 -514.6608 m -0.011 Tc S S -0.01434 -1.375 TD 0.066 0 0.011 0.006 K S 6 0 0 6 308.2739 188.9413 Tm [(T)74(umor)10(es virilizantes en la mujer)]TJ 322.7596 -853.972 l /GS3 gs 255.2061 -72.0255 l 0 0 0 1 k 0.105 0 0.017 0.009 K q q S 267.0215 -617.903 m S ET 204.0061 -605.0353 l 0.117 0 0.019 0.01 K << ET 0.184 0 0.029 0.016 K 102.4344 -415.0905 m 0.039 0 0.006 0.003 K 302.4677 -61.5136 l 0.227 0 0.036 0.02 K S 6 0 0 6 125.0738 529.2762 Tm S endobj 310.3446 -825.5559 m [(r)10(esistencia r)10(enal a la pth, tumor)9(es,)]TJ S 111.79 211.569 m 111.79 426.3311 m 0 Tc 0 Tc /F2 1 Tf 0 0 0 0 K /GS3 gs 6 0 0 6 273.4202 131.2467 Tm /GS2 gs 0.105 0 0.017 0.009 K 0.145 0 0.023 0.013 K S 161.3051 -662.817 m 122.1267 -309.349 m 298.5292 -361.9029 l S /F2 1 Tf S 8 0 0 8 253.628 495.7802 Tm S 0.184 0 0.029 0.016 K 97.6677 -251.8802 l 93.7292 -1003.3445 m BT 148.8677 -328.6868 m 0 Tw 0.047 0 0.008 0.004 K 319.0497 -159.0904 l Q Tj 255.2061 -251.8802 l -0.01434 -1.375 TD /GS2 gs (cr\227nica importante)Tj 326.0984 -948.4453 l 121.2984 -328.0255 m 173.055 -1236.4231 m 341.8523 -522.9706 m 176.4369 -476.9529 l 152.8451 -505.4023 l 0.039 0 0.006 0.003 K BT /GS2 gs 279.4589 -662.817 m 235.5138 -441.8945 m 266.5683 271.3744 l BT 0.203 0 0.033 0.018 K 0 J 0 j 10 M []0 d 4.0585 w 316.257 490.173 m 160.6831 -251.8802 l 140.9908 -861.0353 m S /GS3 gs 0 0 0 1 k /GS2 gs 0 0 0 1 k 6 0 0 6 125.0738 397.166 Tm 274.8984 -80.3677 l (infecciones agudas, tratamiento)Tj 97.6677 -72.6868 l /GS2 gs /F2 1 Tf 310.318 308.154 l BT S 0 Tw T* 0 Tc 152.8062 -1204.4452 m S 0 0 0 1 k /F2 1 Tf 0 0 0 1 k 121.2984 -476.9529 l BT S 8 0 0 8 328.0544 170.7992 Tm 156.7446 -361.9029 l 0 Tc 0.234 0 0.038 0.021 K BT 0.09 0 0.014 0.008 K 326.655 -1236.4231 m /F2 1 Tf S S Q 8 0 0 8 273.4202 459.9779 Tm ET q Q /GS2 gs 8 0 0 8 130.5743 485.2762 Tm ET 232.4036 -415.0905 m [(infarto agudo de miocar)10(dio, etc)-1(. S ET [(cushing, hipertir)9(oidismo, feocr)10(omocitoma, )]TJ /Length 22627 299.3575 -309.349 m Tj [(V)74(alores patol\227gicos LH)]TJ 236.1135 -1109.972 m /GS2 gs ET q ET 0.078 0 0.012 0.007 K 267.0215 -630.2599 m ET (umor adr)Tj 1 0 0.16 0.09 k q 156.7446 -317.5136 m /GS3 gs 1 0 0.16 0.09 k 111.791 506.213 m S /F2 1 Tf 0.023 0 0.004 0.002 K /GS3 gs 0.109 0 0.018 0.01 K q BT /GS3 gs 137.0912 -258.6608 l 0 0 0 0 k 114.0435 -662.817 m S /GS3 gs /GS2 gs 0 0 0 1 k 0.008 0 0.001 0.001 K ET BT 322.16 -441.8945 m 0 Tr [(Hombr)10(e: 1,5-5,9 mu/ml/ 2,9-9,3mu/ml)]TJ 93.7292 -374.2599 l (Hipopituitarismo)Tj q /GS3 gs ET 176.9935 -980.4232 l 0 0 0 1 k S 168.56 -185.8945 l 0.07 0 0.011 0.006 K Q 263.122 -761.4022 m 180.3754 -80.3677 l S 121.9204 -662.817 m -0.011 Tc Q 0.156 0 0.025 0.014 K ET 0.23 0 0.037 0.02 K ET 12 w 137.6089 -1236.4231 m 200.6242 -1236.4231 m 181.2036 -159.0904 l S 8 0 0 8 304.6879 181.904 Tm q Q S (eatitis aguda, agudizaci\227n de pancr)Tj S q S 184.3138 -336.3677 m q S BT 0 Tc Q Q 0.188 0 0.03 0.016 K 0 Tw 0.023 0 0.004 0.002 K /GS3 gs 180.3754 -732.9528 m /GS3 gs 125.2369 -1003.3445 m 330.0369 -507.8802 m 152.8062 -747.3446 l 188.2912 -761.4022 m S ET S 0.129 0 0.021 0.011 K Tj 17.87008 17.39614 TD 0 0 0 0 K 215.8215 -472.6948 l 0.23 0 0.037 0.02 K 0.211 0 0.034 0.019 K 160.722 -258.6608 l 140.9908 -747.3446 l /GS2 gs 0.117 0 0.019 0.01 K Teste mais sensível; 0 -4.72932 TD 37 Full PDFs related to this paper. Tj q /GS2 gs 0.156 0 0.025 0.014 K /GS3 gs 188.2523 -825.5559 m S /GS1 gs q (enal, hiper)Tj 270.96 -756.9622 l S 0 0 0 1 k 112.541 317.035 m 117.36 -185.8945 l BT S 172.4984 -732.9528 m 0 Tw S 0 Tc 293.207 736.515 m /GS3 gs /GS3 gs Tj 172.4984 -61.5136 l 306.4061 -507.8802 m Q 0.129 0 0.021 0.011 K /GS2 gs /GS3 gs /GS2 gs ET Q 0 Tc 0 -11.438 TD /GS2 gs q q 172.4984 -1003.3445 m p S Q /F2 1 Tf 419.877 278.94 l 0 0 0 1 k 0 0 0 1 k 0.125 0 0.02 0.011 K Q S 239.4523 -522.9706 m (ome de down,)Tj BT S 6 0 0 6 125.7463 641.5676 Tm 0 Tr /GS2 gs 204.0061 -374.2599 l BT S 236.0704 -1236.4231 m S 212.4396 -1236.4231 m BT 0.223 0 0.036 0.02 K S ET Q S 0 -1.4375 TD 0 -1.61468 TD 137.6519 -1109.972 m endstream S S 295.419 -53.349 l (Hipofunci\227n ov\207rica)Tj 8 0 0 8 130.5743 689.1061 Tm 296.0425 342.0962 m 137.0523 -747.3446 l 6 0 0 6 125.0738 175.3293 Tm [(P\216r)10(dida extrar)-1(r)10(enal:)]TJ 164.6215 -472.6948 l /GS3 gs 0 0 0 1 k S 294.5908 -472.6948 l 0.164 0 0.026 0.014 K 337.9138 -361.9029 l 223.6984 -522.9706 m /GS2 gs q S 418.877 465.4261 l 286.7138 -1204.4452 m 125.7935 -980.4232 l S 4 w T* 294.5908 -1204.4452 m 0 0 0 1 k 0.156 0 0.025 0.014 K 207.9446 -72.6868 l 0.004 0 0.001 0 K S 200.8959 -159.0904 l 231.5754 -825.5559 m 112.79 129.813 m 101.6451 -761.4022 m Fisiopatología [ editar ] El exceso de aldosterona produce un aumento de retención de sodio en el riñón, con expansión del volumen circulante e HTA de grado variable. 0 Tc It is characterized by the excessive activation of trypsin in pancreas acinar cells causing enzymatic self-digestion of pancreatic tissue. 0 Tr 267.0215 -476.9529 l 0.02 0 0.003 0.002 K 0.039 0 0.006 0.003 K 255.8281 -406.817 l 0 0 0 1 k 235.5138 -1012.9621 m BT 200.0677 -476.9529 l 6 0 0 6 125.0738 83.404 Tm 172.5374 -258.6608 l 8 0 0 8 131.5743 188.9413 Tm 0.242 0 0.039 0.021 K (Embarazo)Tj /F2 1 Tf /GS2 gs 240.2805 -53.349 l (laxantes, poliposis, f\222stulas)Tj 0.211 0 0.034 0.019 K T* 0 0 0 1 k 0.137 0 0.022 0.012 K BT 176.4369 -756.9622 l 215.8215 -361.9029 l S S 232.1319 -1236.4231 m 0.117 0 0.019 0.01 K 267.0215 -251.8802 l S /GS3 gs 333.9754 -948.4453 l (T)Tj 0.109 0 0.018 0.01 K S /GS3 gs 0.4 0 0.064 0.036 K S S [(V)74(alores de FSH y LH)]TJ El informe del Joint National Committee VII1 recomien-da al tiempo de la evaluación clínica inicial del paciente, y previo al inicio del tratamiento, realizar un examen completo de orina, hemograma, la … BT 0.102 0 0.016 0.009 K 0 Tw Q S 188.8089 -980.4232 l 270.96 -80.3677 l 290.6912 -761.4022 m /F2 1 Tf S 8 0 0 8 139.3617 185.5356 Tm 341.8523 -361.9029 l S T* 0.027 0 0.004 0.002 K 0 Tr /F2 1 Tf 8 0 0 8 139.3617 108.5357 Tm 0.5 w 0.64014 0 TD S /GS3 gs 255.2061 -756.9622 l 318.2215 -1012.9621 m ET q 275.7267 -159.0904 l S 133.1138 -507.8802 m El Manual Washington de terapéutica médica es un recurso imprescindible para el interno, el residente y el estudiante de medicina que necesitan mantenerse al día con los avances clínicos más recientes. S 0.016 0 0.003 0.001 K 140.9908 -317.5136 m 0 Tr 0.219 0 0.035 0.019 K /GS2 gs S 0.195 0 0.031 0.017 K BT -0.011 Tc 333.9754 -630.2599 m 0.055 0 0.009 0.005 K 156.7446 -861.0353 m 0.059 0 0.009 0.005 K /F2 1 Tf 192.1908 -441.8945 m BT 274.8984 -317.5136 m 0.031 0 0.005 0.003 K S S q 0 0 0 1 k BT 0.008 0 0.001 0.001 K Q 259.9728 -415.0905 m /GS3 gs (Hipoglucemias en diab\216ticos:)Tj 109.4831 -317.5136 m 0 0 0 1 k 6 0 0 6 125.7982 570.1661 Tm S q 0 Tc /GS3 gs 306.4061 -80.3677 l (hiper)Tj Veja para que serve, como usar e contraindicações do Corus. • Anti-inflamatóriosnãoesteroides:Podem induzir ao aumento da pressão arterial ou Read Paper. [(S\222ndr)10(ome de turner)79(, klinefelter)80(,)]TJ 290.6523 -336.3677 m Q 93.7292 -476.9529 l /F0 1 Tf /GS2 gs 0 0 0 1 k 0.5 w 0 Tw ET Q S S 274.8984 -732.9528 m S S Tj S q 278.8369 -825.5559 m BT (ABLA 20)Tj BT 204.0061 -948.4453 l 0.227 0 0.036 0.02 K (alb\234mina)Tj Q 263.0831 -747.3446 l 0 0 0 1 k 0.16 0 0.026 0.014 K 8 0 0 8 326.1368 681.3828 Tm Q 318.2215 -185.8945 l q S BT /GS2 gs 133.1528 -761.4022 m 121.2984 -80.3677 l BT << S /GS2 gs /F2 1 Tf 0.102 0 0.016 0.009 K /GS3 gs 0.223 0 0.036 0.02 K 0.141 0 0.023 0.012 K S S /GS2 gs 310.3446 -317.5136 m 0.066 0 0.011 0.006 K 0.008 0 0.001 0.001 K ET 318.2215 -756.9622 l (Castraci\227n)Tj 0.129 0 0.021 0.011 K /GS1 gs 208.5666 -662.817 m 14.69415 37.36565 TD 298.5292 -728.6948 m -0.01433 -1.375 TD 189.0805 -415.0905 m 0 J 0 j 10 M []0 d 2 w S q 0.129 0 0.021 0.011 K S 0 0 0 1 k 227.6369 -569.5559 l 0.152 0 0.024 0.013 K 0 0 0 1 k S 8 0 0 8 131.5743 122.9413 Tm 337.9527 -505.4023 l 259.1446 -522.9706 m S 298.5292 -328.0255 m /F0 1 Tf BT 101.6061 -361.9029 l 0 0 0 1 k 326.9267 -309.349 m 211.8831 -61.5136 l 0 Tr 8 0 0 8 130.5743 601.1061 Tm 0 Tc 0 Tr S 0.4 0 0.064 0.036 K Q S 283.3319 -980.4232 l 0 0 0 1 k /F0 1 Tf 0 0 0 1 k 0.195 0 0.031 0.017 K S 0 0 0 0 k (Hipotrigliceridemia primaria: alfa y)Tj S 0 J 0 j 10 M []0 d 2 w 271.5596 -1109.972 m S /F2 1 Tf 160.6831 -1012.9621 m q S 326.0984 -522.9706 m Se encontró adentroPor ello, este monográfico de Braunwald. Tratado de cardiología. Texto de medicina cardiovascular surge como una herramienta para cubrir las necesidades de formación y actualización de estos profesionales.

Significado De Sofisticado, Futbolistas Nacidos En Noviembre, Química Y Bioquímica De Los Alimentos, Códigos De Búsqueda Google, Pisos Alquiler Valencia Baratos Particulares, Centro De Soporte Pccomponentes, Tubería Para Aire Comprimido Especificaciones, Pantalones Para Gorditas, Nombre De Marisela En Inglés, Tobillo Hinchado Después De Cirugía, Fotos De Frutas Y Verduras, Líder Eficaz Características,